Review Article
Volume 10 Issue 2 - 2021
Promising Plant for Covid-19 Purpose: From Basic Science Understanding to Therapeutic Studies
Moyeta Bariso Gare1*, Zelalem Banjaw1, Wondu Reta Demisie1, Tewdros Gebremariam1, Endriyas Kelta1, Minale Fikadie1 and Gemmechu Hasen Godena2
1Department of Biomedical Sciences, Jimma University, Jimma, Ethiopia
2Department of Pharmacy, Jimma University, Jimma, Ethiopia
*Corresponding Author: Moyeta Bariso Gare, Department of Biomedical Sciences, Jimma University, Jimma, Ethiopia.
Received: December 01, 2020; Published: January 30, 2021




Abstract

Background: Moringa plant contains many phytoconstituents such as flavonoids, alkaloids, saponins, saccharides, glucosinolates, tannins, phenolic acids, nitrile glycosides etc. These complex natural phytochemicals contribute to its numerous physiological and pharmacological activities. COVID-19 virus SARS-CoV2 binds its receptor ACE2 and invades alveoli, nephron and other cells of the body and consequently inflammatory mediators like Tumor necrosis alpha (TNF-α), Interleukin-1 (IL-1) and (IL-6) are produced; amplified and further cellular injury will ensue. Moringa plants phytochemicals such as flavonoids is well known in modulation of Renin Angiotensin system (RAS) particularly by inhibiting angiotensin converting enzyme (ACE) which is the homologous of ACE2. It is also known for its inhibitory action against inflammatory mediators IL-1, IL-6 and TNF-α, inhibitory action on reactive oxygen species (ROS). Furthermore, flavonoids containing plants such as Moringa has anti-viral activities.

Objectives: By documenting and linking biological activities of Moringa plants and pathophysiology of COVID-19; it is hoped that this review will provide updated information that might help to re-purpose Moringa plants and other plants with similar phytoconstituents for COVID-19 and its complication.

Methods: The literatures reviewed for this paper were obtained from PubMed and Google Scholar data bases journal papers which were published from 1996 to February 2020.

Keywords: COVID-19; Moringa; Phytochemicals; Flavonoids; Renin Angiotensin System; Inflammatory Mediators; Anti-Viral

References

  1. Chan JF., et al. “A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster”. The Lancet10223 (2020): 514-523.
  2. Seafood H., et al. “International Journal of Infectious Diseases The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in. 91 (2020): 264-266.
  3. Li W., et al. “Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus (2003): 426.
  4. Kuba K., et al. “A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus - induced lung injury 11.8 (2005): 875-879.
  5. Inagami T. “Cloning, expression and regulation of angiotensin II receptors (1996):65-66.
  6. Imai Y., et al. “Angiotensin-converting enzyme 2 protects from severe acute lung failure (2005): 436.
  7. Duan G. of COVID-19. (2020): 1-17.
  8. Li X., et al. “Molecular immune pathogenesis and diagnosis of COVID-19”. Journal of Pharmaceutical Analysis 19 (2020): 1-7.
  9. Wang S., et al. “Intracellular Reactive Oxygen Species Mediate the Therapeutic Effect of Induced Pluripotent Stem Cells for Acute Kidney Injury (2020).
  10. Evaluation of Antidiabetic, Antihyperlipidemic and Antiglycation Effect of Moringa stenopetala (Baker f) Cufodontis leaves A thesis submitted to the School of Graduate Studies of Addis Ababa University in partial fulfillment of the requirements of Doctor of Philosophy Degree (Ph . D) in Pharmacology Evaluation of Antidiabetic, Antihyperlipidemic , and Antiglycation Effect of Moringa stenopetala (Baker f) Cufodontis leaves (2016).
  11. Mekonnen Y and Dräger B. “Glucosinolates in Moringa stenopetala” (2003): 1-3.
  12. Dadi DW., et al. “Effects of spray drying process parameters on the physical properties and digestibility of the microencapsulated product from Moringa stenopetala leaves extract Effects of spray drying process parameters on the physical properties and digestibility of the microencapsulated product from Moringa stenopetala leaves extract”. Cogent Food and Agriculture 1 (2019).
  13. Zahirah N., et al. “Moringa Genus: A Review of Phytochemistry and Pharmacology 9 (2018): 1-26.
  14. Quin M., et al. “Inhibition of Angiotensin-Converting Enzyme Activity by Flavonoids: Structure-Activity Relationship Studies 7.11 (2012): 1-11.
  15. Kumazawa Y., et al. “Immunomodulating Effects of Flavonoids on Acute and Chronic Inflammatory Responses Caused by Tumor Necrosis Factor α” (2006) 4271-4279.
  16. Su H., et al. “Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats 333 (2020): 1339-1346.
  17. Karak P. “Biological Activities Of Flavonoids: An Overview Introduction: Polyphenols are chemical. (2019): 10.
  18. Rota PA., et al. “Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome 300 (2003): 1394-1400.
  19. Grassi D., et al. “Flavonoids and Cocoa flavanols and blood pressure (): 8-11.
  20. Danser AHJ., et al. “Renin-Angiotensin System Blockers and the COVID-19 Pandemic (2020): 1-4.
  21. Peer-reviewed NOT. Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted (2020).
  22. Zheng Y-Y., et al. “Reply to: ‘ Interaction between RAAS inhibitors and ACE2 in the context of COVID-19”. Nature Reviews Cardiology (2020).
  23. Batlle D., et al. “Vascular Angiotensin-Converting Enzyme 2 Lord of the Ring ? (2015): 822-825.
  24. Ace C., et al. “Ultra Rapid Communication A Novel Angiotensin-Converting Enzyme - Related to Angiotensin (2000): 1-9.
  25. Bombardini T and Picano E. “Angiotensin converting enzyme 2 as the molecular bridge between epidemiologic and clinical features of COVID-19”. The Canadian Journal of Cardiology (2020).
  26. Id RT, Vahed SZ., et al. “COVID-19 interactions with angiotensin-converting enzyme 2 (ACE2) and the kinin system; looking at a potential treatment 9.2 (2020): 9-12.
  27. Liu Y., et al. “Anti-hypertensive Angiotensin II receptor blockers associated to mitigation of disease severity in elderly COVID-19 patients (2020).
  28. Kaparianos A and Argyropoulou E. “Local Renin-Angiotensin II Systems, Angiotensin-Converting Enzyme and its Homo- logue ACE2: Their Potential Role in the Pathogenesis of Chronic Obstructive Pulmo- nary Diseases, Pulmonary Hypertension and Acute Respiratory Distress Syndrome c (2011): 3506-3515.
  29. Diaz JH., et al. “Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe (2020): 1-7.
  30. Copyright © 2016 by the Shock Society. Unauthorized reproduction of this article is prohibited 2 (2016).
  31. Meng Y., et al. “Angiotensin-Converting Enzyme 2 / Angiotensin- (1-7)/ Mas Axis 50 (2014): 723-736.
  32. Smith T., et al. “COVID-19 Drug Therapy - Potential Options Highlights : Antimicrobials with potential activity against SARS-CoV-2 (2020).
  33. Michalick L and Kuebler WM. “TRPV4-A Missing Link Between Mechanosensation and Immunity”. Frontiers in Immunology 10 (2020): 11.
  34. Imai Y., et al. Yaghubian-Malhami R. - Google Scholar (2020).
  35. Brandão SCS., et al. “Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?” Cytokine and Growth Factor Reviews (2020).
  36. Costela-Ruiz VJ., et al. “SARS-CoV-2 infection: The role of cytokines in COVID-19 disease”. Cytokine and Growth Factor Reviews 54 (2020): 62-75.
  37. Taylor P. “Flavonoids: Chemical properties and analytical methodologies of identification and quantitation in foods and plants This article was downloaded by: [Lagan, Aldo] Access details: Access Details : [subscription number 934567579] Flavonoids: chemical properties and analytical methodologies of identification and quantitation in foods and plants. 2011 (2016).
  38. Of J and Science N. “Journal of nutritional science (2017): 1-15.
  39. Ghafar F., et al. “Total Phenolic Content And Total Flavonoid Content In Moringa Oleifera Seed Science Heritage Journal / Galeri Warisan Sains ( GWS ). 1.1 (2017): 23-25.
  40. Mohammed S and Manan FA. “Analysis of total phenolics, tannins and flavonoids from Moringa Oleifera seed extract 70.1 (2015): 132-135.
  41. Coppin JP., et al. “Determination of flavonoids by LC / MS and anti-inflammatory activity in Moringa Oleifera”. The Journal of Functional Foods 4 (2013): 1892-1899.
  42. Balasuriya N and Rupasinghe HPV. “Antihypertensive properties of flavonoid-rich apple peel extract”. Food Chemistry 4 (2012): 2320-2325.
  43. Silva WT., et al. “Renoprotective effects of wine flavonoids in nephrotoxicity of the immunosuppressant Tacrolimus 24.3 (2011): 388-392.
  44. Opie LH and Lecour S. “The red wine hypothesis: from concepts to protective signalling molecules (2007): 1683-1693.
  45. Alcorco H. “Transcription factor- B (NF- B) and renal disease” 59 (2001): 415-4
  46. Manuscript A. “NIH Public Access 17.1 (2009): 37-43.
  47. Montezano AC and Touyz RM. “Molecular Mechanisms of Hypertension - Reactive Oxygen Species and Antioxidants: A Basic Science Update for the Clinician”. Christchurch Junior Cricket Association 3 (2012): 288-295.
  48. Lee M. “Quercetin Mitigates Inflammatory Responses Induced by Vascular Endothelial Growth Factor in Mouse Retinal Photoreceptor Cells through Suppression of Nuclear Factor Kappa B (2017).
  49. Schroeter H., et al. “MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide 23 (2002): 861-880.
  50. Tamrat Y., et al. “Anti-inflammatory and analgesic activities of solvent fractions of the leaves of Moringa stenopetala (Moringaceae) in mice models (2017): 1-10.
  51. Leaf M and Bak F. “Experimental Evaluation of Analgesic and Anti-inflammatory Activity of 80 % Experimental Evaluation of Analgesic and Anti-inflammatory Activity of 80 % Methanolic Leaf Extract of Moringa stenopetala F. in Mice” (2015).
  52. Kooltheat N., et al. “An Ethyl Acetate Fraction of Moringa Oleifera Inhibits Human Macrophage Cytokine Production Induced by Cigarette Smoke” (2014): 697-710.
  53. Rocha-pereira J., et al. “Bioorganic and Medicinal Chemistry (E) -2-Styrylchromones as potential anti-norovirus agents”. Bioorganic and Medicinal Chemistry 12 (2010): 4195-4201.
  54. Vergara-jimenez M., et al. “Bioactive Components in Moringa Oleifera Leaves Protect against Chronic Disease (2017): 1-13.
  55. S EA., et al. “Ecotoxicology and Environmental Safety Can secondary metabolites extracted from Moringa seeds suppress ammonia oxidizers to increase nitrogen use efficiency and reduce nitrate contamination in potato tubers? (2019): 185.
  56. Xu Y., et al. “Antioxidant and Anti-Inflammatory Activities of the Crude Extracts of Moringa Oleifera from Kenya and Their Correlations with Flavonoids (2019).
  57. Male DN., et al. “Of the Methanol Extract of Moringa Oleifera” (2017): 1-16.
  58. Fekadu N., et al. “Diuretic activity of the aqueous crude extract and hot tea infusion of Moringa stenopetala (Baker f .) Cufod. leaves in rats (2017): 73-80.
  59. Fej J., et al. “Antioxidant Properties of Moringa Oleifera from Caribbean Island of Saint Lucia (2019): 1-15.
  60. Brindha B., et al. “Biomedicine and Pharmacotherapy Moringa concanensis Nimmo extracts ameliorates hyperglycemia-mediated oxidative stress and upregulates PPAR γ and GLUT4 gene expression in liver and pancreas of streptozotocin-nicotinamide induced diabetic rats (2019): 112.
  61. Mousa AA., et al. “Protective effect of Moringa Oleifera leaves ethanolic extract against thioacetamide-induced hepatotoxicity in rats via modulation of cellular antioxidant, apoptotic and inflammatory markers”. Environmental Science and Pollution Research (2019).
  62. Safaeian L., et al. “The effect of hydroalcoholic extract from the leaves of Moringa peregrina (Forssk.) Fiori. on blood pressure and oxidative status in dexamethasone ‑ induced hypertensive rats (2015): 1-7.
  63. Sohaimy SA El., et al. “Biochemical and functional properties of Moringa Oleifera leaves and their potential as a functional food 4.4 (2015): 188-199.
  64. Atawodi SE., et al. “Biochemistry and 2 Veterinary Public Health and Preventive Medicine Departments, Ahmadu Bello University, Zaria, Nigeria; and 3 Institute for Toxicology and Cancer Risk Factors, German Cancer Research Centre, Heidelberg, Germany 13.3 (2010): 710-716.
  65. Prod JN., et al. “Phytochemical, nutritional and antibacterial properties of dried leaf powder of Moringa Oleifera (Lam) from Edo Central Province, Nigeria 2.1 (2012): 107-112.
  66. Ennett RINB., et al. “Profiling Glucosinolates and Phenolics in Vegetative and Reproductive Tissues of the Multi-Purpose Trees Moringa Oleifera (Horseradish Tree) and Moringa stenopetala L (2003): 3546-53.
  67. Habtemariam S. NPC Natural Product Communications (2015): 1-4.
  68. Parellada J and Suárez G. “Inhibition of Zinc Metallopeptidases by Flavonoids and Related Phenolic Compounds: Structure- Activity Relationships (2009): 5093.
  69. Lee B., et al. “ScienceDirect Antioxidation, angiotensin converting enzyme inhibition activity, nattokinase , and antihypertension of Bacillus subtilis (natto) - fermented pigeon pea 3.398 (2015): 1-8.
  70. Actis-goretta L., et al. “Inhibition of angiotensin converting enzyme (ACE) activity by £ avan-3-ols and procyanidins 555 (2003): 597-600.
  71. Abdulazeez MA., et al. “Antioxidant, Hypolipidemic and Angiotensin Converting Enzyme Inhibitory Effects of Flavonoid- rich Fraction of Hyphaene thebaica (Doum Palm) Fruits on Fat-fed Obese Wistar Rats 5.3 (2019): 1-11.
  72. Bjørklund G., et al. “Flavonoids as detoxifying and pro-survival agents: What ’ s new ? 110 (2017): 240-250.
  73. Lu Y and Foo LY. “Antioxidant and radical scavenging activities of polyphenols from apple pomace 68 (2000): 81-85.
  74. Maaliki D., et al. “ScienceDirect Flavonoids in hypertension: a brief review of the underlying mechanisms”. Current Opinion in Pharmacology 45 (2019): 57-65.
  75. Janine A and Stam S. “Flavonoids, catching up with ACE-inhibitors and angiotensin receptor blockers to treat Diabetic Nephropathy? (2016).
  76. Oretta LUAC., et al. “Inhibition of Angiotensin Converting Enzyme Activity by Flavanol-Rich Foods (2006): 229-234.
  77. Abdulazeez AM., et al. “Partial Purification and Characterization of Angiotensin Converting Enzyme Inhibitory Alkaloids and Flavonoids from the Leaves and Seeds of Moringa Oleifera2 (2016): 1-11.
  78. Khaerunnisa S., et al. “Potential Inhibitor of COVID-19 Main Protease (Mpro) From Several Medicinal Potential Inhibitor of COVID-19 Main Protease (M pro) from Several Medicinal Plant Compounds by Molecular Docking Study (2020).
  79. Kumar K., et al. “Author’ s Accepted Manuscript”. Journal of Ethnopharmacology (2016).
  80. Ariga T. “The antioxidative function, preventive action on disease and utilization of proanthocyanidins 21 (2004): 197-201.
  81. Jiang H and Zhang C. “The Effects of Dracocephalum Heterophyllum Benth Flavonoid on Hypertrophic Cardiomyocytes Induced by Angiotensin II in Rats (2018): 6322-6330.
  82. Iloghalu U., et al. “Selected Plant Extracts Show Antiviral Effects against Murine Norovirus Surrogate (2019): 372-384.
  83. Khalid M., et al. “ScienceDirect Role of flavonoids in plant interactions with the environment and against human pathogens - A review”. Journal of Integrative Agriculture 1 (2019): 211-230.
Citation: Moyeta Bariso Gare., et al. “Promising Plant for Covid-19 Purpose: From Basic Science Understanding to Therapeutic Studies”. EC Pulmonology and Respiratory Medicine 10.2 (2021): 46-58.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


April Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the April issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before April 26, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk